Reaction

Lip Blister reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,693 reports · 41 co-occurring drugs

As of the last recalculation, Lip Blister appears in 2,693 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is GLYCERIN, LIDOCAINE (PRR 51.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Glycerin, Lidocaine	90	51.4	51.7
Docosanol	91	49.6	49.9
Alpelisib	12	10.7	10.7
Diphenhydramine Hydrochloride Capsule, Liquid Filled	29	10.6	10.6
Vemurafenib	10	6.5	6.5
Rucaparib	7	6.1	6.1
Terbinafine Hydrochloride	7	6.1	6.1
Sofosbuvir	15	5.9	5.9
Fexofenadine	12	5.6	5.6
Voriconazole	21	5.4	5.4
Brinzolamide	6	5.3	5.4
Peginterferon Alfa-2A	35	5.1	5.1
Tamsulosin Hydrochloride	13	4.9	4.9
Ivacaftor	5	4.9	4.9
Sunitinib Malate	24	4.8	4.8
Cabozantinib	28	4.5	4.5
Voriconazole Injection	12	4.3	4.3
Varenicline Tartrate	41	4.0	4.0
Ribavirin	33	4.0	4.0
Lapatinib	8	4.0	4.0
Capecitabine	46	3.9	3.9
Asenapine Maleate	4	3.6	3.6
Buprenorphine Hydrochloride, Naloxone Hydrochloride	11	3.5	3.5
Isotretinoin	22	3.5	3.5
Fremanezumab-Vfrm	5	3.4	3.4
Vilazodone Hydrochloride	4	3.4	3.4
Palbociclib	39	3.2	3.2
Asfotase Alfa	4	3.1	3.1
Nicotine Polacrilex	15	3.0	3.0
Nirmatrelvir And Ritonavir	21	3.0	3.0
Budesonide, Glycopyrrolate, And Formoterol Fumarate	4	3.0	3.0
Trametinib	9	2.9	2.9
Umeclidinium Bromide And Vilanterol Trifenatate	6	2.8	2.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	13	2.4	2.4
Ixazomib	9	2.4	2.4
Lenvatinib	10	2.4	2.4
Cenegermin-Bkbj	3	1.9	1.9
Dupilumab	108	1.8	1.8
Sarilumab	6	1.8	1.8
Pirfenidone	7	1.3	1.3
Adapalene	5	0.2	0.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.